Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044787
Filing Date
2024-11-12
Accepted
2024-11-12 16:30:52
Documents
66
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1120681
2 ex31-1.htm EX-31.1 17849
3 ex31-2.htm EX-31.2 18377
4 ex32-1.htm EX-32.1 7340
5 ex32-2.htm EX-32.2 7149
6 form10-q_001.jpg GRAPHIC 19804
  Complete submission text file 0001493152-24-044787.txt   5991864

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE immx-20240930.xsd EX-101.SCH 44460
8 XBRL CALCULATION FILE immx-20240930_cal.xml EX-101.CAL 56763
9 XBRL DEFINITION FILE immx-20240930_def.xml EX-101.DEF 196362
10 XBRL LABEL FILE immx-20240930_lab.xml EX-101.LAB 432325
11 XBRL PRESENTATION FILE immx-20240930_pre.xml EX-101.PRE 332227
68 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 825894
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

EIN.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41159 | Film No.: 241448934
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)